Headline: Tarliarcye Microdart Patches: Revolutionizing Acne Care with 82% Hyaluronic Acid & Salicylic Acid Infusion

Jiangsu Kebesen Biomedical Technology Co., Ltd., a leading innovator in the medical aesthetics industry, is proud to announce the official launch of its flagship product: Tarliarcye Blemish Microdart Patches, a game-changing solution for targeted blemish care that redefines at-home acne treatment.

Unlike traditional acne patches that only work on the skin’s surface, Tarliarcye Microdart Patches feature 170+ dissolving microneedles that penetrate deep into the skin barrier, delivering a potent blend of 82% Hyaluronic Acid and Salicylic Acid directly to the source of blemishes. This innovative delivery system ensures maximum absorption, effectively flattening and smoothing active breakouts, extracting surface impurities, and clarifying blemish-prone skin without irritation.

“At Jiangsu Kebesen, we are committed to bridging medical-grade skincare technology with accessible, consumer-friendly solutions,” said the company’s R&D director. “Our microdart patch is the result of years of clinical research, designed to address the core challenges of acne care: deep penetration, gentle formulation, and visible results.”

Each box contains 16 ultra-thin, hydrocolloid-backed patches that adhere seamlessly to the skin, making them ideal for all-day wear, overnight treatment, or pre-makeup application. The product is now available globally through the company’s official independent website, with international shipping to over 30 countries.